Purpose As the most abundant neuropeptides in Central Nervous System, Substance P and
Neuropeptide Y are arguably involved in the response to brain trauma. This study aims to …

Background Anti-platelet medication and reduced platelet activity are associated with an
increased risk of death after intracerebral hemorrhage (ICH). The optimal assay for …

Background and Purpose—Symptomatic intracerebral hemorrhage (ICH) is a major
complication of thrombolysis in patients with acute ischemic stroke. We analyzed whether …

Objective We evaluated whether reduced platelet activity detected by point-of-care (POC)
testing is a better predictor of hematoma expansion and poor functional outcomes in patients …

Background We investigated the association between international normalised ratio (INR)
and prothrombin time (PT) levels on hospital admission and in-hospital outcomes in acute …

Background It is important to evaluate the likelihood of fatality in patients with acute primary
pontine hemorrhage (PPH) in emergency departments. We aimed to evaluate the clinical …

Thrombolysis by intravenous recombinant tissue plasminogen activator (rt-PA) is an effective
therapy in acute ischemic stroke (AIS). Thrombin generation test (TGT) is a global …

Background and Purpose—Primary intracerebral hemorrhage (PICH) is a devastating
illness with high early mortality. Hypertension is a major risk factor both for ischemic …

Object Primary intracerebral hemorrhage (ICH) carries high morbidity and mortality rates.
Several factors have been suggested as predicting the outcome. The value of C-reactive …